vimarsana.com

Latest Breaking News On - S ravi shankar narayan - Page 1 : vimarsana.com

Remdesivir output up, but supply bottlenecks remain - The Hindu BusinessLine

Remdesivir output up, but supply bottlenecks remain × The production of most sought after anti-viral drug, Remdesivir, has increased significantly but its availability continues to be a challenge in some States and private hospitals. The production capacity of the remdesivir injection by seven domestic manufacturers has increased from 38 lakh vials per month to nearly 119 lakh vials, the Ministry of Chemicals and Fertilisers said on Monday. Developed by US-based Gilead Sciences Inc, Remdesivir is being used to treat Covid-19 patients with oxygen saturation below 95 per cent and those with moderate to severe symptoms. Hyderabad-based Hetero Drugs is a major manufacturer of Remdisivir followed by Cipla, Zydus Cadila, Mylan Labs, Dr Reddy’s Labs, Syngene and Jubilant Ingrevia.

Coronavirus live updates | India currently accounts for one in every two global cases each day

A second wave of the virus and another exodus Amid the sustained surge in COVID-19 cases, migrant workers in the city, who had come back to the Capital a few months ago, are forced to return to their villages, yet again due to the pandemic-induced lockdown. For most, the second phase of restrictions has meant a loss of livelihood for the second time within a year. When the Delhi government announced a one-week lockdown, many had hoped it would not get extended. But that was not to be. Read a detailed report here. Maharashtra NMMC issues notices to three hospitals for asking patients’ kin to arrange Remdesivir

A P receives 82,000 vials of Remdesivir

Steps on to check misuse of drug: DCA Andhra Pradesh has received 82,000 vials of Remdesivir injections in the second phase. In the first phase, 60,000 vials were allotted to the State, said the Drug Control Administration (DCA) officials. “The Remdesivir stock has been allotted for the period between May 1 and 9. So far, the Centre has allotted 1.42 lakh vials of Remdesivir to the State during the second wave of the pandemic,” said DCA Director General (DG) S. Ravi Shankar Narayan. With the incidents of misuse and black marketing of Remdesivir injections, the State government is supplying the stocks to the notified COVID hospitals and monitoring the stock of Remdesivir and oxygen at various hospitals.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.